Bausch Health Companies (TSE:BHC) Trading 25.9% Higher – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC)’s stock price shot up 25.9% on Thursday . The company traded as high as C$8.50 and last traded at C$8.26. Approximately 2,448,423 shares traded hands during trading, an increase of 398% from the average session volume of 491,244 shares. The stock had previously closed at C$6.56.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Wednesday, July 22nd. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, Bausch Health Companies has an average rating of “Hold”.

Bausch Health Companies Stock Up 14.5%

The company has a current ratio of 1.32, a quick ratio of 0.58 and a debt-to-equity ratio of -1,009.96. The company has a market capitalization of C$3.60 billion, a price-to-earnings ratio of -2.98, a PEG ratio of 0.21 and a beta of 0.97. The firm’s 50 day simple moving average is C$7.02 and its 200-day simple moving average is C$7.57.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings data on Wednesday, July 29th. The company reported C$1.79 EPS for the quarter. Bausch Health Companies had a negative net margin of 12.02% and a positive return on equity of 109.94%. The company had revenue of C$4.05 billion during the quarter. On average, sell-side analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.